Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression

Emilie Doz, Stéphanie Rose, Nathalie Court, Sophie Front, Virginie Vasseur, Sabine Charron, Martine Gilleron, Germain Puzo, Isabelle Frémaux, Yves Delneste,

Journal of Biological Chemistry · 2009 · 62 citations · 54 references

DOIFull text

Open access

Concepts

Abstract

Mycobacterium tuberculosis modulates host immune responses through proteins and complex glycolipids. Here, we report that the glycosylphosphatidylinositol anchor phosphatidyl-myo-inositol hexamannosides PIM6 or PIM2 exert potent anti-inflammatory activities. PIM strongly inhibited the Toll-like receptor (TLR4) and myeloid differentiation protein 88 (MyD88)-mediated release of NO, cytokines, and chemokines, including tumor necrosis factor (TNF), interleukin 12 (IL-12) p40, IL-6, keratinocyte-derived chemokine, and also IL-10 by lipopolysaccharide (LPS)-activated macrophages. This effect was independent of the presence of TLR2. PIM also reduced the LPS-induced MyD88-independent, TIR domain-containing adaptor protein inducing interferon β (TRIF)-mediated expression of co-stimulatory receptors. PIM inhibited LPS/TLR4-induced NFκB translocation. Synthetic PIM1 and a PIM2 mimetic recapitulated these in vitro activities and inhibited endotoxin-induced airway inflammation, TNF and keratinocyte-derived chemokine secretion, and neutrophil recruitment in vivo. Mannosyl, two acyl chains, and phosphatidyl residues are essential for PIM anti-inflammatory activity, whereas the inosityl moiety is dispensable. Therefore, PIM exert potent antiinflammatory effects both in vitro and in vivo that may contribute to the strategy developed by mycobacteria for repressing the host innate immunity, and synthetic PIM analogs represent powerful anti-inflammatory leads. Mycobacterium tuberculosis modulates host immune responses through proteins and complex glycolipids. Here, we report that the glycosylphosphatidylinositol anchor phosphatidyl-myo-inositol hexamannosides PIM6 or PIM2 exert potent anti-inflammatory activities. PIM strongly inhibited the Toll-like receptor (TLR4) and myeloid differentiation protein 88 (MyD88)-mediated release of NO, cytokines, and chemokines, including tumor necrosis factor (TNF), interleukin 12 (IL-12) p40, IL-6, keratinocyte-derived chemokine, and also IL-10 by lipopolysaccharide (LPS)-activated macrophages. This effect was independent of the presence of TLR2. PIM also reduced the LPS-induced MyD88-independent, TIR domain-containing adaptor protein inducing interferon β (TRIF)-mediated expression of co-stimulatory receptors. PIM inhibited LPS/TLR4-induced NFκB translocation. Synthetic PIM1 and a PIM2 mimetic recapitulated these in vitro activities and inhibited endotoxin-induced airway inflammation, TNF and keratinocyte-derived chemokine secretion, and neutrophil recruitment in vivo. Mannosyl, two acyl chains, and phosphatidyl residues are essential for PIM anti-inflammatory activity, whereas the inosityl moiety is dispensable. Therefore, PIM exert potent antiinflammatory effects both in vitro and in vivo that may contribute to the strategy developed by mycobacteria for repressing the host innate immunity, and synthetic PIM analogs represent powerful anti-inflammatory leads. Multifold interactions between Mycobacterium tuberculosis and host phagocytes determine immune responses to M. tuberculosis and tuberculosis pathogenesis (for review, see Refs. 1.Flynn J.L. Chan J. Annu. Rev. Immunol. 2001; 19: 93-129Crossref PubMed Scopus (1730) Google Scholar and 2.Flynn J.L. Microbes Infect. 2006; 8: 1179-1188Crossref PubMed Scopus (192) Google Scholar). Alveolar macrophages, the primary host cells for M. tuberculosis, and dendritic cells that carry mycobacterial antigens from the infection site to the draining lymph nodes to establish a T cell-mediated immune response contribute to modulate the innate immune response by secreting cytokines after recognition of microbial motives. Among them, TNF 2The abbreviations used are: TNFtumor necrosis factorILinterleukinLPSlipopolysaccharideBCGbacillus Calmette GuérinDC-SIGNdendritic cell-specific intracellular adhesion molecule-3 grabbing nonintegrinKCkeratinocyte-derived chemokineMRmannose receptorLAMlipoarabinomannanLMlipomannansManmannosyl unitManLAMmannose-capped LAMMyD88myeloid differentiation protein 88PIphosphatidyl-myo-inositolPIMPI mannosidesTLRToll-like receptorMTT3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromideGPIglycosylphosphatidylinositolTRIFTIR domain-containing adaptor protein inducing interferon βKOknock out.2The abbreviations used are: TNFtumor necrosis factorILinterleukinLPSlipopolysaccharideBCGbacillus Calmette GuérinDC-SIGNdendritic cell-specific intracellular adhesion molecule-3 grabbing nonintegrinKCkeratinocyte-derived chemokineMRmannose receptorLAMlipoarabinomannanLMlipomannansManmannosyl unitManLAMmannose-capped LAMMyD88myeloid differentiation protein 88PIphosphatidyl-myo-inositolPIMPI mannosidesTLRToll-like receptorMTT3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromideGPIglycosylphosphatidylinositolTRIFTIR domain-containing adaptor protein inducing interferon βKOknock out. is an essential mediator for granuloma formation and containment of M. tuberculosis infection. Similarly, IL-12, interferon γ, but also IL-1, IL-18, IL-23, and nitric oxide are required for host defense (1.Flynn J.L. Chan J. Annu. Rev. Immunol. 2001; 19: 93-129Crossref PubMed Scopus (1730) Google Scholar, 2.Flynn J.L. Microbes Infect. 2006; 8: 1179-1188Crossref PubMed Scopus (192) Google Scholar, 3.Cooper A.M. Kipnis A. Turner J. Magram J. Ferrante J. Orme I.M. J. Immunol. 2002; 168: 1322-1327Crossref PubMed Scopus (264) Google Scholar, 4.Jouanguy E. Lamhamedi-Cherradi S. Altare F. Fondanèche M.C. Tuerlinckx D. Blanche S. Emile J.F. Gaillard J.L. Schreiber R. Levin M. Fischer A. Hivroz C. Casanova J.L. J. Clin. Invest. 1997; 100: 2658-2664Crossref PubMed Scopus (327) Google Scholar, 5.Altare F. Durandy A. Lammas D. Emile J.F. Lamhamedi S. Le Deist F. Drysdale P. Jouanguy E. Döffinger R. Bernaudin F. Jeppsson O. Gollob J.A. Meinl E. Segal A.W. Fischer A. Kumararatne D. Casanova J.L. Science. 1998; 280: 1432-1435Crossref PubMed Scopus (731) Google Scholar, 6.Fremond C.M. Togbe D. Doz E. Rose S. Vasseur V. Maillet I. Jacobs M. Ryffel B. Quesniaux V.F. J. Immunol. 2007; 179: 1178-1189Crossref PubMed Scopus (266) Google Scholar). Phagocytes are also a source of immuno-modulatory cytokines, such as IL-10 and transforming growth factor-β, which dampen the immune response and inflammation. Mycobacteria-derived molecules down-modulating the immune system have been described, including the protein ESAT-6, mannose-capped lipoarabinomannan (ManLAM), and lipomannans (LM) (7.Pathak S.K. Basu S. Basu K.K. Banerjee A. Pathak S. Bhattacharyya A. Kaisho T. Kundu M. Basu J. Nat. Immunol. 2007; 8: 610-618Crossref PubMed Scopus (298) Google Scholar, 8.Nigou J. Zelle-Rieser C. Gilleron M. Thurnher M. Puzo G. J. Immunol. 2001; 166: 7477-7485Crossref PubMed Scopus (353) Google Scholar, 9.Geijtenbeek T.B. Van Vliet S.J. Koppel E.A. Sanchez-Hernandez M. Vandenbroucke-Grauls C.M. Appelmelk B. Van Kooyk Y. J. Exp. Med. 2003; 197: 7-17Crossref PubMed Scopus (895) Google Scholar, 10.Gringhuis S.I. den Dunnen J. Litjens M. van Het Hof B. van Kooyk Y. Geijtenbeek T.B. Immunity. 2007; 26: 605-616Abstract Full Text Full Text PDF PubMed Scopus (478) Google Scholar, 11.Quesniaux V.J. Nicolle D.M. Torres D. Kremer L. Guérardel Y. Nigou J. Puzo G. Erard F. Ryffel B. J. Immunol. 2004; 172: 4425-4434Crossref PubMed Scopus (211) Google Scholar, 12.Doz E. Rose S. Nigou J. Gilleron M. Puzo G. Erard F. Ryffel B. Quesniaux V.F. J. Biol. Chem. 2007; 282: 26014-26025Abstract Full Text Full Text PDF PubMed Scopus (91) Google Scholar). Here, we report that phosphatidyl-myo-inositol mannosides (PIM), the glycosylphosphatidylinositol (GPI) anchor structure of LAM and LM, exert strong anti-inflammatory activities. tumor necrosis factor interleukin lipopolysaccharide bacillus Calmette Guérin dendritic cell-specific intracellular adhesion molecule-3 grabbing nonintegrin keratinocyte-derived chemokine mannose receptor lipoarabinomannan lipomannans mannosyl unit mannose-capped LAM myeloid differentiation protein 88 phosphatidyl-myo-inositol PI mannosides Toll-like receptor 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide glycosylphosphatidylinositol TIR domain-containing adaptor protein inducing interferon β knock out. tumor necrosis factor interleukin lipopolysaccharide bacillus Calmette Guérin dendritic cell-specific intracellular adhesion molecule-3 grabbing nonintegrin keratinocyte-derived chemokine mannose receptor lipoarabinomannan lipomannans mannosyl unit mannose-capped LAM myeloid differentiation protein 88 phosphatidyl-myo-inositol PI mannosides Toll-like receptor 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide glycosylphosphatidylinositol TIR domain-containing adaptor protein inducing interferon β knock out. Mycobacterial cell wall LAM, LM, and PIM are recognized by macrophages and dendritic cells through various pattern recognition receptors, including Toll-like receptors (TLRs) (13.Brightbill H.D. Libraty D.H. Krutzik S.R. Yang R.B. Belisle J.T. Bleharski J.R. Maitland M. Norgard M.V. Plevy S.E. Smale S.T. Brennan P.J. Bloom B.R. Godowski P.J. Modlin R.L. Science. 1999; 285: 732-736Crossref PubMed Scopus (1402) Google Scholar, 14.Heldwein K.A. Fenton M.J. Microbes Infect. 2002; 4: 937-944Crossref PubMed Scopus (133) Google Scholar, 15.Stenger S. Modlin R.L. Curr. Opin. Immunol. 2002; 14: 452-457Crossref PubMed Scopus (109) Google Scholar, 16.Takeda K. Kaisho T. Akira S. Annu. Rev. Immunol. 2003; 21: 335-376Crossref PubMed Scopus (4729) Google Scholar) and C-type lectins such as mannose receptor (MR/CD206) and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN/CD209), central to M. tuberculosis binding and internalization by human dendritic cells (17.Tailleux L. Schwartz O. Herrmann J.L. Pivert E. Jackson M. Amara A. Legres L. Dreher D. Nicod L.P. Gluckman J.C. Lagrange P.H. Gicquel B. Neyrolles O. J. Exp. Med. 2003; 197: 121-127Crossref PubMed Scopus (531) Google Scholar, 18.Maeda N. Nigou J. Herrmann J.L. Jackson M. Amara A. Lagrange P.H. Puzo G. Gicquel B. Neyrolles O. J. Biol. Chem. 2003; 278: 5513-5516Abstract Full Text Full Text PDF PubMed Scopus (222) Google Scholar, 19.Pitarque S. Herrmann J.L. Duteyrat J.L. Jackson M. Stewart G.R. Lecointe F. Payre B. Schwartz O. Young D.B. Marchal G. Lagrange P.H. Puzo G. Gicquel B. Nigou J. Neyrolles O. Biochem. J. 2005; 392: 615-624Crossref PubMed Scopus (89) Google Scholar, 20.Torrelles J.B. Azad A.K. Schlesinger L.S. J. Immunol. 2006; 177: 1805-1816Crossref PubMed Scopus (150) Google Scholar). DC-SIGN and mannose receptor were proposed to mediate ManLAM inhibition of LPS-induced IL-12 production in dendritic cells, an activity ascribed to the mannosylated cap (8.Nigou J. Zelle-Rieser C. Gilleron M. Thurnher M. Puzo G. J. Immunol. 2001; 166: 7477-7485Crossref PubMed Scopus (353) Google Scholar, 9.Geijtenbeek T.B. Van Vliet S.J. Koppel E.A. Sanchez-Hernandez M. Vandenbroucke-Grauls C.M. Appelmelk B. Van Kooyk Y. J. Exp. Med. 2003; 197: 7-17Crossref PubMed Scopus (895) Google Scholar). We showed recently that mycobacterial LM have a dual potential for pro-inflammatory and anti-inflammatory effects (11.Quesniaux V.J. Nicolle D.M. Torres D. Kremer L. Guérardel Y. Nigou J. Puzo G. Erard F. Ryffel B. J. Immunol. 2004; 172: 4425-4434Crossref PubMed Scopus (211) Google Scholar), tri- and tetra-acylated LM fractions exerting stimulatory effects through TLR2, TLR4, and MyD88 (21.Gilleron M. Nigou J. Nicolle D. Quesniaux V. Puzo G. Chem. Biol. 2006; 13: 39-47Abstract Full Text Full Text PDF PubMed Scopus (89) Google Scholar), whereas diacylated LM inhibit LPS-induced cytokine response independently of TLR2, SIGN-R1, and mannose receptor E. Rose S. Nigou J. Gilleron M. Puzo G. Erard F. Ryffel B. Quesniaux V.F. J. Biol. Chem. 2007; 282: 26014-26025Abstract Full Text Full Text PDF PubMed Scopus (91) Google Scholar). PIM are of LM and LAM A. Brennan P.J. D. PubMed Scopus Google Scholar, C.M. Brennan P.J. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar, M. Nigou J. B. Puzo G. J. Biol. 1999; 285: PubMed Scopus Google Scholar, J. Gilleron M. Puzo G. Brennan P.J. Gicquel B. K. Jackson M. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). and PIM are the two of PIM in M. tuberculosis and Mycobacterium PIM and acyl to tetra-acylated for PIM for two for and for see for both PIM2 and PIM6 M. C. M. B. G. Puzo G. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar, M. Quesniaux V.F. Puzo G. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar, J. J. 2007; PubMed Scopus Google Scholar, J. J. 2007; PubMed Scopus Google Scholar). PIM mannose were to human and to contribute to J.B. Azad A.K. Schlesinger L.S. J. Immunol. 2006; 177: 1805-1816Crossref PubMed Scopus (150) Google Scholar). of PIM the whereas PIM2 was recognized by DC-SIGN independently of of the PIM recently been A. 2003; PubMed Scopus Google Scholar, P.H. J. Chem. 2006; PubMed Scopus Google Scholar, M. J. Chem. 2007; PubMed Scopus Google Scholar, S. M. B. P.H. J. Chem. PubMed Scopus Google Scholar). Here, we acyl of PIM and PIM2 and PIM6 but also synthetic PIM1 and a mimetic of PIM2 as strong of endotoxin-induced responses in vitro and in vivo. macrophages from we PIM effects and NFκB complex mycobacterial ManLAM and LM but also PIM are potent of host was through of the M. A. Puzo G. J. Biol. Chem. Full Text PDF PubMed Google Scholar) as in Gilleron M. C. M. B. G. Puzo G. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). M. PIM2 and PIM6 and tetra-acylated were as by Gilleron (21.Gilleron M. Nigou J. Nicolle D. Quesniaux V. Puzo G. Chem. Biol. 2006; 13: 39-47Abstract Full Text Full Text PDF PubMed Scopus (89) Google Scholar). of the acyl was by and PIM1 a and a in the unit was A. 2003; PubMed Scopus Google Scholar, M. J. Chem. 2007; PubMed Scopus Google Scholar, M. C.M. Med. Chem. 2006; 14: PubMed Scopus Google Scholar, J. J.L. Med. Chem. 2006; 14: PubMed Scopus Google Scholar) (for see the was by an PIM2 mimetic was by of in the presence of of the the as used in the of and by (for the of the and (for see the for A. M. T. S. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar), MyD88 T. O. T. K. Akira S. Immunity. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), M. S. K. Kaisho T. O. M. M. K. Akira S. Science. 2003; PubMed Scopus Google Scholar), S.K. S. A. S. Van L. Immunity. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar), M.J. J. Exp. Med. PubMed Scopus Google Scholar), mannose receptor S.J. S. D. J. L. T. M.C. Science. 2002; PubMed Scopus Google Scholar), or A. P. S. M.J. J. Exp. Med. 2004; PubMed Scopus Google Scholar) and were the cells were from and for in essential and as a source of a in the cell a of macrophages macrophages in essential and were synthetic or of PIM or are the the PIM were in and to the a macrophages were to IL-12 and the were after for cells were the for expression or macrophages, and cells were also in the presence of of of the was macrophages PIM as for in and were for and NFκB were by were for and from which was from and a and were and for cytokine for IL-6, and IL-12 in cell were the as J. S.R. Biochem. PubMed Scopus Google Scholar). of the cytokine and chemokine was by of macrophages and after in the presence of synthetic PIM2 mimetic of and was used for from E. in PIM1 or PIM2 mimetic in or was by in a of was by a of J. M. D. P. M. C. M. J. Immunol. 1998; Google Scholar). as a of airway (for see S. Quesniaux V.F. F. Maillet I. N. I. R. Erard F. Ryffel B. B. J. Immunol. 2005; PubMed Scopus Google Scholar) was and activity was in and was as S. Quesniaux V.F. F. Maillet I. N. I. R. Erard F. Ryffel B. B. J. Immunol. 2005; PubMed Scopus Google Scholar) for cytokine and cell cells was by of by the of were PIM TNF production by a cell K.A. P.J. Belisle J.T. Fenton M.J. J. Biol. 2001; Google Scholar), and we showed that PIM6 are also M. Quesniaux V.F. Puzo G. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). LM and anti-inflammatory activities were to the of of the LM we PIM fractions also inhibit of PIM6 was from M. M. C. M. B. G. Puzo G. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar) and acyl to were as M. Quesniaux V.F. Puzo G. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). effect of and fractions LPS-induced TNF was cell and primary macrophages of TNF release were PIM6 and whereas was and inhibition was were for release PIM fractions were and a which a fractions inhibited TNF and by primary macrophages of PIM was to a a cell the K.A. P.J. Belisle J.T. Fenton M.J. J. Biol. 2001; Google Scholar), and we showed that the in response to PIM2 and PIM6 fractions was the M. Quesniaux V.F. Puzo G. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). We recognition was in the PIM anti-inflammatory activity macrophages from for TLR2. effect of PIM fractions LPS-induced TNF was independent of recognition by TLR2, as cells for were inhibited by the PIM6 acyl fractions inhibition of LPS-induced TNF by or was in the of TLR2, which by activity, whereas is required for the inhibition of LPS-induced cytokine release by PIM We the effects of the PIM fractions were for the and were used to macrophages in the or in presence of PIM and inhibited the production of and TNF and after by but after by or effect of PIM fractions IL-12 expression after was and was also after Therefore, the effects of the PIM fractions are to the the for IL-12 the activity in PIM fractions and to the anti-inflammatory activity from the activity the we a PI and Synthetic PIM1 inhibited the LPS-induced of IL-12 and as as the fractions PIM6 or whereas synthetic PI PIM1 was stimulatory for cytokine or production the used through we that the anti-inflammatory activities in the fractions was the PIM the PIM anti-inflammatory from the pro-inflammatory activity and that a PIM structure was for the anti-inflammatory the of we a that the of the and acyl chains, two the and the by a of the complex was to interferon release by in vitro G. J.L. Scholar). We the activity of the PIM2 mimetic macrophages in to synthetic and to a of the PIM2 of acyl residues PIM2 mimetic strongly inhibited the production of TNF and IL-12 p40, whereas the was and the were stimulatory to PIM2 mimetic synthetic PIM1 and and was of the presence of a mannose PIM2 mimetic was the PIM2 mimetic and PIM2 strongly inhibited the production of IL-12 and TNF but also IL-10 and by macrophages, and were potent that a mannose moiety may the of the moiety by a PIM2 mimetic activity that the inosityl moiety is for the anti-inflammatory activity, the moiety is Therefore, such PIM2 are by and the anti-inflammatory activities in or synthetic through two the or we the effects of the PIM fractions of these PIM activity in macrophages. cytokine release is strongly the MyD88 C.M. V. Nicolle D.M. Jacobs M. Quesniaux V.F. Ryffel B. J. Clin. Invest. 2004; PubMed Scopus Google Scholar) but independent of IL-12 p40, IL-6, and release by macrophages was strongly inhibited by synthetic PIM1 whereas PI was to is in macrophages and IL-6, or release after by which a was inhibited by PIM1 of that PIM inhibition of cytokine or release in response to was independent of the We the expression of the co-stimulatory molecules and which and MyD88-independent, was by PIM LPS-induced expression of co-stimulatory molecules such as was reduced in the presence of synthetic PIM1 but of PI in macrophages LPS-induced and expression was in macrophages and expression of LPS-induced and was also strongly reduced in the presence of but of in macrophages and Therefore, PIM1 inhibited both from the cytokine and release and the MyD88-independent, expression of co-stimulatory molecules and expression of and is and we PIM activity NFκB translocation. NFκB is in macrophages and after the presence of PIM1 or PIM2 cells NFκB after were by and were after that NFκB was in the presence of PIM we that PIM2 mimetic inhibited the release of TNF and IL-12 in primary including and macrophages Therefore, PIM1 and PIM2 mimetic reduced LPS-induced NFκB and the cytokine effect was primary TNF is essential for as in S. Quesniaux V.F. F. Maillet I. N. I. R. Erard F. Ryffel B. B. J. Immunol. 2005; PubMed Scopus Google Scholar, D. S.I. N. I. Maillet I. Jacobs M. M. L. Quesniaux V.F. B. S. J. Immunol. 2007; PubMed Scopus Google Scholar). We the inhibition of cytokine release by synthetic PIM1 or PIM2 mimetic was for the airway response to to of developed an of which was by of PIM1 or PIM2 mimetic and recruitment of cells, in the after was by of PIM1 or PIM2 mimetic and were in the by activity the LPS-induced of and the neutrophil chemokine, was reduced by PIM1 and PIM2 mimetic and showed strong and neutrophil after which was reduced in the presence of PIM1 or PIM2 mimetic both by LPS-induced macrophages in vitro PIM1 and PIM2 mimetic inhibited the expression of a of pro-inflammatory and cytokines, including p40, IL-12 IL-18, and interferon β but also of IL-10 as as after in vitro Therefore, the synthetic PIM1 or PIM2 mimetic inhibited the airway in response to in an activity potent inhibition of a of and infection by M. tuberculosis of the but in of is and to the immune of the immune a between the mycobacteria and the host mycobacterial including the protein ESAT-6, or the cell wall complex LAM or LM the host immune responses (7.Pathak S.K. Basu S. Basu K.K. Banerjee A. Pathak S. Bhattacharyya A. Kaisho T. Kundu M. Basu J. Nat. Immunol. 2007; 8: 610-618Crossref PubMed Scopus (298) Google Scholar, 8.Nigou J. Zelle-Rieser C. Gilleron M. Thurnher M. Puzo G. J. Immunol. 2001; 166: 7477-7485Crossref PubMed Scopus (353) Google Scholar, 9.Geijtenbeek T.B. Van Vliet S.J. Koppel E.A. Sanchez-Hernandez M. Vandenbroucke-Grauls C.M. Appelmelk B. Van Kooyk Y. J. Exp. Med. 2003; 197: 7-17Crossref PubMed Scopus (895) Google Scholar, 10.Gringhuis S.I. den Dunnen J. Litjens M. van Het Hof B. van Kooyk Y. Geijtenbeek T.B. Immunity. 2007; 26: 605-616Abstract Full Text Full Text PDF PubMed Scopus (478) Google Scholar, 11.Quesniaux V.J. Nicolle D.M. Torres D. Kremer L. Guérardel Y. Nigou J. Puzo G. Erard F. Ryffel B. J. Immunol. 2004; 172: 4425-4434Crossref PubMed Scopus (211) Google Scholar, 12.Doz E. Rose S. Nigou J. Gilleron M. Puzo G. Erard F. Ryffel B. Quesniaux V.F. J. Biol. Chem. 2007; 282: 26014-26025Abstract Full Text Full Text PDF PubMed Scopus (91) Google Scholar). we that the to in also strongly the host immune of mannosyl and two are required the PIM to inhibit the LPS-induced the of cytokine and release were and whereas was and was We that an whereas was that two are required the LM to inhibit the LPS-induced TNF whereas or acyl are LM pro-inflammatory activity (11.Quesniaux V.J. Nicolle D.M. Torres D. Kremer L. Guérardel Y. Nigou J. Puzo G. Erard F. Ryffel B. J. Immunol. 2004; 172: 4425-4434Crossref PubMed Scopus (211) Google Scholar, 12.Doz E. Rose S. Nigou J. Gilleron M. Puzo G. Erard F. Ryffel B. Quesniaux V.F. J. Biol. Chem. 2007; 282: 26014-26025Abstract Full Text Full Text PDF PubMed Scopus (91) Google Scholar, M. Nigou J. Nicolle D. Quesniaux V. Puzo G. Chem. Biol. 2006; 13: 39-47Abstract Full Text Full Text PDF PubMed Scopus (89) Google Scholar). of M. ManLAM was also to inhibit LPS-induced IL-12 production by human dendritic cells (8.Nigou J. Zelle-Rieser C. Gilleron M. Thurnher M. Puzo G. J. Immunol. 2001; 166: 7477-7485Crossref PubMed Scopus (353) Google Scholar). that the PIM structure two was required and for anti-inflammatory activity, we we that a synthetic of PIM1 was a potent of LPS-induced release of cytokines and in whereas which the mannosyl was synthetic PIM we that the inosityl moiety is for the anti-inflammatory activity, whereas the is ManLAM anti-inflammatory activity been ascribed to the of the anti-inflammatory cytokine IL-10 T.B. Van Vliet S.J. Koppel E.A. Sanchez-Hernandez M. Vandenbroucke-Grauls C.M. Appelmelk B. Van Kooyk Y. J. Exp. Med. 2003; 197: 7-17Crossref PubMed Scopus (895) Google Scholar, 10.Gringhuis S.I. den Dunnen J. Litjens M. van Het Hof B. van Kooyk Y. Geijtenbeek T.B. Immunity. 2007; 26: 605-616Abstract Full Text Full Text PDF PubMed Scopus (478) Google Scholar) through C-type lectins such as the mannose receptor and PIM activity was by IL-10 as PIM strongly inhibited pro-inflammatory cytokines p40, and but also IL-10 the inhibition of responses was of a effect as the expression of a of LPS-induced cytokines and was inhibited by PIM as as after the of C-type lectins mannose receptor and PIM inhibition of response and PIM6 have a for human molecules J. S. D. D.B. Y. M. Modlin R.L. Immunity. 1998; 8: Full Text Full Text PDF PubMed Scopus Google Scholar) and PIM2 to D.M. J. Immunol. 2006; 177: PubMed Scopus Google Scholar), we macrophages that binding to was required for PIM inhibition of cytokines PIM inhibited by but also by such as M. tuberculosis LM E. Rose S. Nigou J. Gilleron M. Puzo G. Erard F. Ryffel B. Quesniaux V.F. J. Biol. Chem. 2007; 282: 26014-26025Abstract Full Text Full Text PDF PubMed Scopus (91) Google Scholar) or a synthetic F. Nicolle D.M. D. C. Ryffel B. Quesniaux V.F. 2006; PubMed Scopus Google Scholar) the by TLR4, PIM inhibited the of pro-inflammatory cytokines but also the MyD88-independent, expression of co-stimulatory to cytokine in response to is NFκB and translocation. Here, we showed a effect of PIM NFκB by PIM are of mycobacterial LAM and LAM the of cells through S. S. M. Brennan P.J. J. Immunol. Google Scholar). PIM6 inhibited LAM and the moiety was as PI was as LAM in host molecules S. S. M. Brennan P.J. J. Immunol. Google Scholar). the molecules have been to contribute to the of host immune response by such as or have been to host from TNF and IL-12 expression J. C. M. M. J. Immunol. 1997; Google Scholar), and moiety of T. reduced IL-6, and IL-12 release IL-10 B. M. L. J. M. Van J. P. S. J. Immunol. 2007; 179: PubMed Scopus Google Scholar). we that PIM are a potent for mycobacteria to dampen and the host immune PIM activities are from of mycobacterial proteins such as ESAT-6, through and and of through IL-10 and to the mannosylated in PIM PIM activities are also from of T. as are through IL-10 and PIM of complex between and in the presence of a such as C. M. T. T. B. D. N. C. J. Immunol. PubMed Scopus Google Scholar). PIM the formation or the interactions of we were to PIM inhibition of LPS-induced IL-12 of to IL-12 such as that the that the primary complex is by We PIM contribute to the of the innate immune response in vivo. PIM of the mycobacterial and are to the and cells D. PubMed Scopus Google Scholar), was to determine PIM dampen the innate immune responses in the a for mycobacterial we that of synthetic PIM1 or PIM2 mimetic inhibit in of cytokine and chemokine secretion, cell recruitment in the and airway PIM2 analogs such as PIM2 mimetic that or the activity in or synthetic PIM are of as potential leads. we report the anti-inflammatory activities of of PIM release may represent an of the host innate for PIM contribute to dampen the of macrophages and cells in the granuloma and contribute to the immune response in infection. PIM also represent a molecules potential as We are to M. C. for the of the mannose to S. Akira for the and to P. G. of for and A. N. for to the and and to Nigou for

References

54